🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
61.36
-0.63 (-1.02%)
At close: Nov 19, 2026, 4:00 PM EST
60.14
-1.22 (-1.99%)
After-hours: Nov 19, 2026, 4:44 PM EST

Eton Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
141.0679.9539.0131.6421.2521.83
Revenue Growth
100.61%104.94%23.29%48.90%-2.66%55879.49%
Cost of Revenue
40.6232.1215.610.586.932.83
Gross Profit
100.4447.8323.4121.0614.3219.01
Selling, General & Admin
46.3635.2422.3418.9318.5814.27
Research & Development
9.927.773.263.3246.23
Operating Expenses
56.284325.5922.2522.5820.5
Operating Income
44.164.83-2.18-1.19-8.26-1.5
Interest Expense
-4.32-4.78-2.01-1.06-0.96-1.04
Interest & Investment Income
1.071.070.791.560.190.04
Other Non Operating Income (Expenses)
-0.37-----
EBT Excluding Unusual Items
40.541.12-3.39-0.69-9.02-2.5
Merger & Restructuring Charges
-3.47-5.68-0.42---
Gain (Loss) on Sale of Assets
-----0.18
Other Unusual Items
-----0.37
Pretax Income
37.06-4.56-3.81-0.69-9.02-1.96
Income Tax Expense
-12.80.040.020.25--
Net Income
49.86-4.6-3.82-0.94-9.02-1.96
Net Income to Common
49.86-4.6-3.82-0.94-9.02-1.96
Net Income Growth
------
Shares Outstanding (Basic)
282726262525
Shares Outstanding (Diluted)
312726262525
Shares Change
17.20%3.91%0.97%1.99%-0.24%19.98%
EPS (Basic)
1.80-0.17-0.15-0.04-0.36-0.08
EPS (Diluted)
1.60-0.17-0.15-0.04-0.36-0.08
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
38.2210.190.946.824.78-4.73
Free Cash Flow Per Share
1.220.380.040.270.19-0.19
Gross Margin
71.20%59.83%60.01%66.56%67.38%87.05%
Operating Margin
31.30%6.04%-5.59%-3.77%-38.87%-6.85%
Profit Margin
35.35%-5.75%-9.80%-2.96%-42.45%-8.96%
Free Cash Flow Margin
27.09%12.75%2.42%21.54%22.51%-21.66%
EBITDA
49.148.88-1.04-0.29-6.49-1.12
EBITDA Margin
34.83%11.10%-2.66%-0.92%-30.52%-5.13%
D&A For EBITDA
4.984.041.150.91.770.37
EBIT
44.164.83-2.18-1.19-8.26-1.5
EBIT Margin
31.30%6.04%-5.59%-3.77%-38.87%-6.85%
Revenue as Reported
141.0679.9539.0131.6421.2521.83
SEC Filings: 10-K · 10-Q